MapLight Therapeutics, Inc.

MPLT Nasdaq CIK: 0001770069

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Mailing Address 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Phone 650-839-4360
Fiscal Year End 1231
EIN 832163243

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 12, 2026 View on SEC
4 Insider stock transaction report February 12, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 4, 2026 View on SEC

IPO Filings

S-1 September 19, 2025
  • Portfolio of brain-targeted drugs addressing major neurological conditions (autism, Parkinson’s, schizophrenia, Alzheimer’s psychosis) with a late-stage candidate (ML-007C-MA).
  • Innovative 'brain circuit repair' approach for precision treatment, potentially offering fewer side effects than existing therapies.
View Analysis

Insider Trading

STRONG SELL 2 insiders 9 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.